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Abstract
Background—Comparisons of incidence and mortality rates are the metrics used most commonly
to define cancer-related racial disparities. In the US, and particularly in South Carolina, these largely
disfavor African Americans (AAs). Computed from readily available data sources, the mortality-toincidence rate ratio (MIR) provides a population-based indicator of survival.
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Methods—South Carolina Central Cancer Registry incidence data and Vital Registry death data
were used to construct MIRs. ArcGIS 9.2 mapping software was used to map cancer MIRs by sex
and race for 8 Health Regions within South Carolina for all cancers combined and for breast, cervical,
colorectal, lung, oral, and prostate cancers.
Results—Racial differences in cancer MIRs were observed for both sexes for all cancers combined
and for most individual sites. The largest racial differences were observed for female breast, prostate,
and oral cancers, and AAs had MIRs nearly twice those of European Americans (EAs).
Conclusions—Comparing and mapping race- and sex-specific cancer MIRs provides a powerful
way to observe the scope of the cancer problem. By using these methods, in the current study, AAs
had much higher cancer MIRs compared with EAs for most cancer sites in nearly all regions of South
Carolina. Future work must be directed at explaining and addressing the underlying differences in
cancer outcomes by region and race. MIR mapping allows for pinpointing areas where future research
has the greatest likelihood of identifying the causes of large, persistent, cancer-related disparities.
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Fax: (803) 734-5259; E-mail: jhebert@sc.edu.

Hébert et al.

Page 2

Other regions with access to high-quality data may find it useful to compare MIRs and conduct MIR
mapping.
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In the US, as in most countries, both incidence and mortality are expressed per unit population
(eg, typically per 100,000 population/year).1 Incidence rates are sensitive to a variety of
influences, especially efforts aimed at early detection (with concomitant down-staging of
disease and at least temporary increases in apparent incidence).2 Given a reasonable
understanding of the relation between early detection, stage at diagnosis, and overall incidence,
3 an incidence rate based on the overall population at risk over a specified period is a reasonable
comparative parameter.
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Cancer incidence rates often are cited to support claims of cancer disparities between subgroups
within populations.4,5 Considerable heterogeneity exists in site-specific cancer incidence rates
by race/ethnicity, and overall disparities are greatest among African Americans (AAs)
compared with any other racial/ethnic subgroup of the US population.1 Although incidence
usually is greater among AAs, mortality rates typically diverge to a greater extent.6,7 These
rate elevations tend to be more extreme (up to 50% higher for some cancers) in South Carolina
than in other places in the US, indeed, even compared with other places in the world.7-15
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Although mortality is a very sensitive indicator of disparities, without accounting for incidence
it can be very misleading. High mortality can result from very poor survival in a cancer with
moderate or even low incidence. By contrast, high mortality can result from even moderate
survival in a very high-incidence cancer. Across populations and even within racial groups in
different parts of the US, mortality does not track well with incidence for a variety of reasons
related to screening/early detection, differences in treatment and follow-up, and the aggressive
nature of certain cancers, especially hormone-sensitive cancers that are detected at early ages.
5-7,16 For example, in South Carolina mortality per unit incidence is much higher among AAs
than among European Americans (EAs) for both breast and prostate cancers; although the
incidence of breast cancer is lower among AAs,11 the incidence of prostate cancer is much
higher among AAs.9 Both of these cancers tend to occur at younger ages in AAs than in EAs.
Because preventing deaths must be an important part of any competent cancer prevention and
control effort, the statistics described in this study address an important need: to describe
mortality in relation to incidence.
The mortality-to-incidence ratio (MIR), which can be computed relatively easily from existing
sources of data, may deepen our understanding of the factors that cause departures of mortality
rates from expectations based on incidence. These factors may range from true biologic
differences in the virulence of disease to health system-related attributes, including access to
screening, diagnostic services, treatment, and follow-up. Despite the additional information
that the MIR can convey, there are very few references in the literature to the use of this
parameter in comparing cancer rates.17-22 Virtually none of those studies used populationbased data from US registry sources.
In addition to providing an accessible indicator of survival by combining mortality and
incidence, mapping of MIR allows for discerning differences in geographic regions wherein
individuals may have particularly worse (or better) prognoses for a given cancer diagnosis.
This enables researchers to target limited resources more efficiently by pinpointing areas in
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which in-depth study can identify potentially modifiable causes of large, persistent, cancerrelated disparities in disease virulence. To illustrate the utility of MIR mapping to highlight
particular regions that evince extreme divergences in MIR by sex and race, we used the state
of South Carolina, a geopolitical entity with extreme cancer disparities disfavoring AAs7-15
and with excellent sources of relevant data.

Materials and Methods
Definition of Race and Ethnicity
Although racial designations are far from perfect,23 the epidemiologic evidence indicates
consistently that race (geographic origin), rather than skin color, is related more strongly to
known or suspected cultural and biologic determinants of cancer.4,24 The vast majority of
blacks, both in the US and in South Carolina, are of predominantly African origin, and the vast
majority of whites are of predominantly European origin.7,23 Therefore, in this report, we use
the more specific, if still imperfect, terms “African American (AA)” and “European American
(EA)” as the racial designators of choice.
Incidence Data
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By law, incident cancers in South Carolina state residents are required to be reported to the
South Carolina Central Cancer Registry (SCCCR). Housed within the South Carolina
Department of Health and Environmental Control (DHEC) Office of Public Health Statistics
and Information Services (PHSIS), the SCCCR was established in 1994 with funds awarded
from the National Program of Cancer Registries (NPCR). In 1996, enabling legislation was
passed by the South Carolina General Assembly, and data collection began. Both in situ (except
for cervical cancers) and invasive cancers (except for basal and squamous cell skin cancers of
nongenital sites) are collected from hospitals, pathology laboratories, freestanding treatment
centers, and physician offices.
Currently, the SCCCR has data-sharing agreements with 20 states to ensure that the vast
majority of incident cases are reported. Since its inception, the SCCCR consistently has
received the highest (ie, gold) rating for data completeness (>97.5%), timeliness, and quality
from the North American Association of Central Cancer Registries and the NPCR. Currently,
100% of all cancers (cases and deaths) are geocoded; 82% are coded to a point-level address
that can be linked to information in approximately 25 datasets from other state data sources
ranging from hospital discharges to death registration.
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In situ cancers were excluded from the current analyses, which is the convention in comparing
incidence rates. Patients with in situ (ie, noninvasive) disease would not be expected to die of
that cancer. However, staging error is a possibility. This was of concern primarily for breast
cancer. Because of this exclusion, an additional quality-control check was conducted on the
incidence data to assure that exclusion of in situ cases did not bias the results. Therefore, the
most currently available linked file (2001-2005 incidence file linked to 2001-2005 cancer
mortality file) was used to determine whether any of the in situ cases matched after controlling
for multiple primary tumors.
Mortality Data
Each state requires, by law, the registration of births and deaths. An estimated 99% of births
and deaths are registered in the US. Yearly, the Divisions of Vital Registry and Biostatistics
within the office of PHSIS, DHEC, provides cancer mortality data to the SCCCR for use in
statistical analysis. The Vital Registry Division is responsible for providing vital information
pertaining to births, deaths, marriages, and divorces occurring in South Carolina, whereas the
Division of Biostatistics is responsible for registering, collecting, analyzing, and disseminating
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all vital events that occur in South Carolina. Mortality statistics are based on information found
on death certificates of South Carolina residents. Underlying causes of death are classified
according to the International Classification of Disease, Tenth Edition. Interjurisdictional
exchange agreements with all states are in place to capture out-of-state deaths of South Carolina
residents.
South Carolina Department of Health and Environmental Control Regions 1 Through 8
The South Carolina DHEC has divided the state of South Carolina into 8 Health Regions for
the purposes of administering health and environmental programs. The state is predominantly
rural; the largest city, Columbia, has a population of only approximately 120,000. Each region
is approximately 12.5% (or an eighth) the size of the state or approximately 4000 square miles.
Within each region, offices provide local support to the public primarily through health clinics
and environmental quality control, which includes air and water quality as well as land and
waste management.

NIH-PA Author Manuscript

Although the Health Regions are defined administratively, they correspond to both ecologic
zones and racial differences. For example, Regions 6 through 8 are located on a low, flat, coastal
plain that consists of sandy soils.25 AA representation is highest in the state, and the amount
of European genetic admixture among AAs is the lowest in the state, especially in Regions 7
and 8,26 which, in the 18th and 19th centuries, had the highest concentrations of rice and cotton
cultivation in the US.27 Although equally rural, Regions 3 through 5 represent the transitional
zone in terms of soils (sandy to clay), topography (rolling hills), and intermediate levels of AA
representation and European genetic admixture (not as low as the coastal areas but still much
lower than the US average). Regions 1 and 2 represent the transition to the Piedmont. Soils in
this hilly region tend to be rocky and claylike, agriculture tends toward fruit cultivation (eg,
peaches), the economy is driven more by major automotive industries (eg, BMW and
Michelin), and the lowest proportional AA population in the state has the highest level of
European genetic admixture.26
Calculated Measures: Mortality-to-Incidence Ratios and Their 95% Confidence Intervals
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Age-adjusted incidence and mortality rates were calculated using incidence data from 2001 to
2005 in the SCCCR and mortality data from 2001 to 2005 in the DHEC Vital Registry. The
MIRs were calculated as the age-adjusted mortality rate divided by the age-adjusted incidence
rate for each cancer. These MIRs were computed for the 8 DHEC Health Regions representing
South Carolina's 4.3 million residents by race and sex over all cancers and for the following
solid tumor types: breast, cervical, colorectal, lung, oral, and prostate. MIRs also were
computed for EAs in the US as a whole for all cancers combined and for the 6 cancer sites.
Then, these MIRs were used to compare with race-, sex-, and Health Region-specific MIRs
within South Carolina. In addition, we computed 95% confidence intervals (95% CIs) for race
and, where appropriate, sex-specific MIRs by race for the state as a whole. The 95% CIs were
calculated in R version 2.6.1 Patched statistical software package28,29 using methods
proposed by Fay30 for directly standardized rates (DSRs) with sparse data. This method uses
F intervals, which approximate exact DSR intervals and are a function of the estimated means
and variances of the DSR. The F intervals are different from exact DSR intervals (which assume
a multiplicative Poisson model and may not be calculated using standard algorithms for exact
tests) and generally are more conservative than other methods (eg, standard-log transformed,
normal, approximated intervals; Cornfield intervals) but guarantee nominal coverage.
For the purposes of comparison in the maps, we defined 4 categories for all cancers, for each
cancer separately, and for sex category when appropriate. The upper bound of Category 1 is
the mean for EAs nationally (ie, for the US as a whole); the upper bound of Category 2 is 10%
higher than the upper bound of Category 1, the upper bound of Category 3 is 20% higher than
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the upper bound of Category 1, and Category 4 consists of MIRs >20% higher than the national
mean for EAs (ie, above the upper bound of Category 3).
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Mapping Mortality-to-Incidence Ratios
We used the SCCCR cancer incidence and Vital Registry mortality datasets with the calculated
MIRs and determined categories in ESRI ArcGIS software (version 9.2). Standard ArcGIS
mapping procedures were used to map all cancers combined as well as the following anatomic
sites: breast, cervical, colorectal, lung, oral, and prostate. We used the ArcGIS software
capability to contrast MIRs, by race and sex, shown for each of the 8 DHEC Health Regions
in South Carolina in the accompanying maps.31

Results
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For purposes of placing population centers in geographic context, we provide a map of South
Carolina (Fig. 1). The state covers 31,113 square miles and has approximately 4.3 million
residents. It is a relatively poor state with a median income only 81% of that for the US as a
whole.32 Nearly 40% of the state is considered rural.33 Compared with other states, a large
proportion (approximately 31%) of the population is comprised of AAs, many of whom live
in rural areas.33,34 A higher proportion of AAs than EAs live in rural areas, which is different
from other places in the US (outside of the Southeast), in which AAs reside predominately in
urban settings.33,34
Our analyses of breast cancer cases diagnosed with in situ disease revealed that 10 such cases
were identified for the 5-year period with a single primary tumor that was linked to a death
from the same cancer type. These 10 cases were reviewed for staging accuracy by supporting
records submitted from the hospital. Follow back to the hospital was performed if sufficient
records were not available to support the stage. For these 10 cases, no further information could
be gleaned that justified changing the disease stage. Because of this small number of in situ
cancer deaths, we determined that they would not have a meaningful impact on the MIRs. All
subsequent analyses shown here excluded data from cases diagnosed with in situ disease.
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Table 1 shows the South Carolina MIRs and associated 95% CIs by race and sex for breast,
cervical, colorec-tal, lung, oral cavity, and prostate cancers and for all cancer sites combined.
For all cancers combined, EA women (MIR, 0.37) had the best survival in general, whereas
AA men (MIR, 0.50) had the worst. The MIR differences between race groups for both breast
and cervical cancers in women, for oral cancer in both sexes, and for prostate cancer in men
were striking; ie, 55%, 50%, 85%, and 58% higher, respectively, among AAs than among EAs.
Colorectal cancer MIRs were somewhat higher among AA women than among EA women
(only 17%; ie, nonsignificantly higher) but were 26% higher among AA men than among EA
men. Lung cancer, which was the most fatal of the 6 cancers that we analyzed, was associated
with MIRs that were similar by race, although men with lung cancer had approximately 14.5%
higher mortality, on average, than women with lung cancer.
The MIRs are shown by DHEC Health Region in Figure 2 for all cancers combined, in Figure
3 for colorectal cancer, in Figure 4 for oral cancer, in Figure 5 for female breast cancer, in
Figure 6 for cervical cancer, in Figure 7 for prostate cancer, and in Figure 8 for lung cancer.
In examining the data from Figure 2, there were large (>20% higher) racial differences for
cancers as a whole in both sexes. AA men had a higher MIR than EA men in all but 1 region
of the state. For women, the results were more striking, with at least a 2-category difference
in 7 regions and a 3-category (ie, maximal) difference in 3 of the coastal and the upstate regions.
In a pattern generally consistent with overall cancers, colorectal cancer (Fig. 3) evinced
moderate to large differences by race. AAs in every region had higher MIRs than EAs; in 2
regions, the rates were 2 categories higher, and 3 regions evinced a 3-category difference.
Cancer. Author manuscript; available in PMC 2010 June 1.
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In 1 inland region, EAs were in the highest MIR category for oral cancer (Fig. 4), whereas AAs
were in the highest MIR category in all but 1 region in the state. Breast cancer (Fig. 5) exhibited
some of the largest racial differences by region in terms of MIR, with AA women in 7 of 8
regions falling into the highest MIR category and EA women falling into the lowest category
in 6 regions and into the second category in 2 regions. For cervical cancer (Fig. 6), 1 region
(Region 8) had the lowest MIR for both races. However, for every other region, AAs had a
higher MIR than AAs; and in 5 regions their MIRs fell into the highest category. The differences
in the MIRs for prostate cancer (Fig. 7) were extreme, with AA MIRs in the highest category
in 7 of the 8 regions and EA MIRs in the lowest category in 5 regions. For lung cancer (Fig.
8), the MIRs were higher for AAs in 4 regions, and no region had an AA MIR >20% higher
than the equivalent EA MIR.

Discussion
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It is well known that, for many cancer sites, both incidence and mortality rates are elevated in
AAs compared with EAs1 and that inter-racial differences tend to be more extreme in South
Carolina.7-15 Comparing subpopulation-specific MIRs allows for greater insight by assessing
mortality and incidence jointly. For example, breast cancer mortality-given incidence among
AA women is >60% in excess of what we would predict based on incidence alone (compare
the race-specific MIRs in Table 1.). Although prostate cancer is nearly 80% higher among AA
men than among EA men1, the mortality-given incidence is nearly 60% higher than among
AA. Although this result supports earlier findings,1,11 such differences can be explored much
more effectively using MIRs. In addition, this method provides a standard population-based
approximation of survival by stabilizing the incidence and mortality differences across cancer
sites and race groups. It does so without resorting to survival studies, which are expensive,
time-consuming, and fraught with logistical difficulties concerning minority participation and
patient follow-up.
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We observed large differences in MIR by race for all cancers combined, for all of the sexspecific cancers (female breast, cervix, and prostate), for oral cancers in both sexes, and for
colorectal cancers in men (Table 1). The size of the MIR differences observed by race is
noteworthy. For example, the oral cancer MIR in AA men is approximately twice as high as
it is in EA men (0.44 vs 0.23). This is a remarkable difference, in that it is larger in magnitude
than the difference between what normally is considered a relatively poor prognosis cancer
(colon: average MIR, approximately 0.37 in the US as a whole) and what is associated with
an excellent prognosis (female breast: average MIR, approximately 0.20).1 Consistent with
the overall differences observed (Table 1), mapping of the MIR for these sites by sex and race
revealed striking differences across the 8 DHEC regions for female breast, cervical, colorectal,
oral, and prostate cancers and for all cancers combined.
The current results sharpen and deepen our understanding of patterns of mortality-given
incidence. It is also noteworthy that they are consistent with known survival differences by
cancer type, sex, race, and US region.1 Although crude differences in these parameters have
been widely reported in the literature,3-5,35,36 to the best of our knowledge, there have been
no previous attempts to test mortality-by-incidence rate differences by race or to map them to
geographic coordinates. Computing and comparing MIRs can deepen our understanding of the
fate of individuals who are diagnosed with cancer. Mapping them in geographic space can
highlight differences in general and for specific types of cancer (eg, by anatomic site,
histopathologic grade) with respect to geographic region, sex, and race.
The racial differences by sex illustrated in our study reveal similar patterns to those observed
previously in other South Carolina-based reports.7,15 Of the 4 race-sex combinations, AA men
had the highest overall MIRs. In addition, based on their absolute rate of dying from cancer
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(ie, the difference in MIRs based on subtraction), AA men have far worse cancer outcomes
compared with their EA counterparts than AA women compared with EA women. This is likely
because of a complex set of biologic and social differences, such as higher rates of poverty and
diminished socioeconomic opportunity among AA men, who tend to be worse off by any
measure—from income to incarceration, education, and a wide variety of health indicators.
37-40 Although the proportional differences (ie, obtained by dividing the MIRs) often are larger
by race among women (eg, for overall cancers, AA women have an MIR that is 26% higher
than EA women, whereas AA men have an MIR that is 16% higher than EA men), the absolute
MIRs almost always are higher in men than in women.

NIH-PA Author Manuscript

Although AAs tend to use less tobacco than EAs, and tobacco use among AA women is
particularly low,7,41 relative differences in the MIR are the most extreme for oral cancer
especially among men (1.91 times higher in AAs) but also among women (1.52 times higher
in AAs). By using MIRs, we exert implicit control for incidence. For example, although oral
cancer incidence rates are higher for AAs than for EAs,13 the MIR remains much higher for
AAs across the state, reflecting more fatalities from these cancers among AAs (Fig. 4). This
suggests that more powerful risk factors may be operative in the AA population or that effect
modification functions differentially across the races. This is an important area for research,
because we would expect that risk reduction in EA populations with tobacco cessation would
differ from AA populations (it could be higher or lower). It also might point to some other
factor (eg, diet) that is particularly important in AAs. MIRs for cervical cancer, which is another
tobacco-related cancer, were equally discrepant except in Region 8 (Fig. 5).
Although mapping incidence and mortality data in this way cannot pinpoint causative or
mediating factors or identify particular mechanisms responsible for these differences that are
distributed differentially by geographic location, this method can be used to identify target
areas for screening as well as areas for future research into both primary and secondary
prevention of cancer. The MIR method has great utility in pinpointing specific places in need
of timely, focused, additional attention (both for future study at the individual level and for the
allocation of public health resources). For example, the Pee Dee, an area of extreme poverty
contained in Region 4, had high MIRs for most cancers among AAs. This pattern also was
observed in some of the central and north coastal areas (Regions 6 and 7). It was interesting
that no consistent pattern of decreased MIRs was observed around urban centers where major
hospital systems are located, such as Charleston (contained in Region 7), Columbia (contained
in Region 3), and Greenville and Spartanburg (contained in Region 2). However, Greenville
is close to Region 1, for which we noted anomalously low MIRs, especially for colorectal and
cervical cancers, cancers for which screening is a form of primary prevention.
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Future efforts might focus on comorbidities or environmental risk factors, including such
spatially distributed variables as pollutant exposures and characteristics of the built
environment (eg, local access to locations for physical activity or food outlets). These
environmental exposures could be assessed at the individual level (eg, residential distances to
food outlets or pollutant exposure levels) or at the aggregate level (eg, census tract) and
combined with behavioral and health status indicators collected from individuals (perhaps
including disease-free individuals enrolled as part of a cohort based in high-risk areas).
Individual-level variables might include risk factors such as diet and physical activity as well
as those related to the use of preventive procedures (eg, screening) and cancer treatment.
Because South Carolina is a very rural state with relatively low literacy and high rates of
poverty,32-34 these factors may be strongly operative and, thus, need to be taken into
consideration. The ability to map cancer incidence and mortality across a variety of factors that
are distributed differentially in space and with an ability to link to individual-level information
creates considerable scope for both defining and solving the problem.

Cancer. Author manuscript; available in PMC 2010 June 1.

Hébert et al.

Page 8

Strengths and Weaknesses
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Selection bias often affects population-based studies. For this study, virtually the entire
population is represented. Cancer incidence data provided by the SCCCR is excellent, with an
estimated >97.5% of all incident cancers captured. Information on mortality used to compute
the MIR and the ability of the SCCCR to geocode this information also are excellent, with all
cases geocoded and >80% of these mapped to patient point-level addresses. In and out
migration of cancer patients is minimal and is not particularly problematic for computing these
MIRs. In addition, we were able to combine multiple years of data (2001-2005) to produce
MIRs that were more stable than had we been constrained to using only a few years previously
in areas with smaller sample sizes and higher levels o in and out migration.42
High MIRs may be explained by deficiencies in early detection that leads to up-staging of
disease.3,19 The high incidence rates for most cancers argue against this as the driver of very
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high MIRs in AAs. According to the 2006 Behavior Risk Factor Surveillance System, 86.8%
of women in South Carolina reported having had a Papanicolaou test within the past 3 years,
approaching the Healthy People 2010 goal of 90%.43 With a 2006 mammogram screening rate
of 74.5% for women in South Carolina aged >39 years, the Health People 2010 goal of 70%
for screening within the past 2 years was surpassed. Among men aged ≥40 years, 56.3%
reported having had a prostate-specific antigen measurement in the past 3 years. Although there
is no Healthy People 2010 goal regarding prostate-specific antigen measurements, this figure
is slightly higher than the US rate of 53.5%.43,44 These finding are consistent with South
Carolina's intensive efforts aimed at broad-based screening for common cancers, such as breast,
cervical, and prostate cancers. In addition, screening rates were very similar by race,9-11 and
recent data indicate that screening explains only a portion of survival differences in
Surveillance, Epidemiology, and End Results data.45
Cancers of all sites have a natural variability in both occurrence and mortality in different years,
and this may have an impact on the precision of the MIRs. Most individuals who are diagnosed
with cancer do not die of their disease. Those who do die survive for a wide variety of times.
Therefore, no simple relation exists between the denominator represented by cancer incidence
and the numerator represented by cancer-specific mortality. Therefore, some simplifying
assumptions were needed to compute the MIR. Despite its deficiencies, it must be kept in mind
that the MIR can be computed relatively easily from existing sources of relatively complete
data. The alternative would require conducting survival studies, most likely in the context of
extremely large cohorts that are expensive, time-consuming, and methodologically difficult.
46 Because of issues related to access and selection, these kinds of studies have an inherent
bias that results in excluding the economically disadvantaged individuals who were identified
using the MIR approach as being at very high risk of dying from cancer.47
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In conclusion, the results from this study, taking advantage of South Carolina's excellent data
resources, describe a striking elevation in MIRs for most cancers among AAs compared with
EAs in nearly all regions of the state. The ability to link across geocoded datasets creates
remarkable scope for conducting analyses that can lead to understanding the causes of large
racial disparities in cancer mortality. Future work might entail performing analyses at smaller
levels of aggregation, perhaps at the individual level, to understand why AAs have such high
rates of mortality after they are diagnosed with one of these common cancers. We encourage
other states and geographic entities to conduct similar sorts of descriptive analyses.
Understanding the causes of increased mortality from cancer is critical if we hope to end these
cancer-related disparities that are so starkly evident using the MIR method.
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FIGURE 1.

Population centers shown in geographic context. AA indicates African American.
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FIGURE 2.

Mortality-to-incidence (M:I) rate ratios by South Carolina Department of Health and
Environmental Control (SC DHEC) Health Region for all cancers combined in (A) males and
(B) females. CDC indicates Centers for Disease Control and Prevention; ACS, American
Cancer Society; PHSIS, Public Health Statistics and Information Services; C.M.M., Center for
Medicare and Medicaid Services.
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FIGURE 3.
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Mortality-to-incidence (M:I) rate ratios by South Carolina Department of Health and
Environmental Control (SC DHEC) Health Region for colorectal cancer. CDC indicates
Centers for Disease Control and Prevention; ACS, American Cancer Society; PHSIS, Public
Health Statistics and Information Services; C.M.M., Center for Medicare and Medicaid
Services.

Cancer. Author manuscript; available in PMC 2010 June 1.

Hébert et al.

Page 15

NIH-PA Author Manuscript
NIH-PA Author Manuscript
FIGURE 4.

Mortality-to-incidence (M:I) rate ratios by South Carolina Department of Health and
Environmental Control (SC DHEC) Health Region for oral cancer. CDC indicates Centers for
Disease Control and Prevention; ACS, American Cancer Society; PHSIS, Public Health
Statistics and Information Services; C.M.M., Center for Medicare and Medicaid Services.
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FIGURE 5.

Mortality-to-incidence (M:I) rate ratios by South Carolina Department of Health and
Environmental Control (SC DHEC) Health Region for female breast cancer. CDC indicates
Centers for Disease Control and Prevention; ACS, American Cancer Society; PHSIS, Public
Health Statistics and Information Services; C.M.M., Center for Medicare and Medicaid
Services.
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FIGURE 6.

Mortality-to-incidence (M:I) rate ratios by South Carolina Department of Health and
Environmental Control (SC DHEC) Health Region for cervical cancer. CDC indicates Centers
for Disease Control and Prevention; ACS, American Cancer Society; PHSIS, Public Health
Statistics and Information Services; C.M.M., Center for Medicare and Medicaid Services.
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FIGURE 7.

Mortality-to-incidence (M:I) rate ratios by South Carolina Department of Health and
Environmental Control (SC DHEC) Health Region for prostate cancer. CDC indicates Centers
for Disease Control and Prevention; ACS, American Cancer Society; PHSIS, Public Health
Statistics and Information Services; C.M.M., Center for Medicare and Medicaid Services.
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FIGURE 8.

Mortality-to-incidence (M:I) rate ratios by South Carolina Department of Health and
Environmental Control (SC DHEC) Health Region for lung cancer. CDC indicates Centers for
Disease Control and Prevention; ACS, American Cancer Society; PHSIS, Public Health
Statistics and Information Services; C.M.M., Center for Medicare and Medicaid Services.
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Table 1

South Carolina Mortality-to-Incidence Ratios and 95% Confidence Intervals for All Cancer Sites Combined and
Specified Cancer Sites by Race and Sex, 2001-2005
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Blacks (African Americans)*

Whites (European Americans)*

Cancer Site

MIR

95% CI

MIR

95% CI

All cancer sites combined†

0.479

0.468-0.490‡

0.400

0.395-0.405‡

Women†

0.470

0.454-0.486‡

0.373

0.366-0.381‡

Men†

0.499

0.484-0.515‡

0.430

0.422-0.438‡

Breast†,§

0.292

0.271-0.314‡

0.188

0.179-0.197‡

Cervix†,§

0.410

0.335-0.500‡

0.273

0.228-0.325‡

0.418

0.390-0.447‡

0.344

0.330-0.360‡

Women

0.395

0.359-0.435

0.337

0.316-0.359

Men†

0.442

0.400-0.488‡

0.352

0.331-0.375‡

0.838

0.795-0.882

0.807

0.786-0.829

Women

0.775

0.708-0.848

0.760

0.729-0.793

Men

0.880

0.824-0.940

0.848

0.818-0.878

0.414

0.359-0.476‡

0.224

0.201-0.250‡

Women†

0.346

0.247-0.480

0.228

0.186-0.279

Men†

0.436

0.371-0.513‡

0.225

0.197-0.257‡

0.259

0.241-0.277‡

0.164

0.155-0.174‡

Colon/rectum (overall)

Lung (overall)

NIH-PA Author Manuscript

Oral cavity (overall)†

Prostatey†,‖

MIR indicates mortality-to-incidence ratio; 95% CI, 95% confidence interval.
*

The terms black and white are used in cancer registration; these are for South Carolina as a whole.

†
A statistically significant difference was observed in the MIR between African Americans and European Americans.
‡
Nonoverlapping 95% CI.
§

Women only.

‖

Men only.
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